Daniel P. O'Day - 10 Jun 2022 Form 4 Insider Report for GILEAD SCIENCES, INC. (GILD)

Role
Chairman & CEO, Director
Signature
/s/ Edward S. Son by Power of Attorney for Daniel P. O'Day
Issuer symbol
GILD
Transactions as of
10 Jun 2022
Transactions value $
-$93,479
Form type
4
Filing time
13 Jun 2022, 19:59:10 UTC
Previous filing
14 Mar 2022
Next filing
12 Sep 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GILD Common Stock Options Exercise +3.3K +1.32% 253K 10 Jun 2022 Direct F1
transaction GILD Common Stock Tax liability -$93.5K -1.54K -0.61% $60.74 251K 10 Jun 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GILD Restricted Stock Unit Options Exercise -3.3K -2.4% 134K 10 Jun 2022 Common Stock 3.3K Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.
F2 The restricted stock units have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested.